Jérôme Clerc

2.9k citations

83 papers · 1.9k indexed · h-index 25

Impact in

Endocrinology, Diabetes and Metabolism top 2%
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
Radiology, Nuclear Medicine and Imaging top 5%
- Radiomics and Machine Learning in Medical Imaging
- Medical Imaging Techniques and Applications

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 30
- Thyroid Cancer Diagnosis and Treatment 27
- Thyroid Disorders and Treatments 16
Radiology, Nuclear Medicine and Imaging 23
- Cardiac Imaging and Diagnostics 8
- Medical Imaging Techniques and Applications 7

Co-authors: Markus Kaiser (10 shared papers)Anne‐Ségolène Cottereau (9 shared papers)André S. Bachmann (6 shared papers)Olivier Casasnovas (5 shared papers)Irène Buvat (5 shared papers)M. Groll (5 shared papers)Michel Meignan (4 shared papers)Robert Dudler (5 shared papers)
Journals: Journal of Nuclear Medicine (5 papers)Cancers (3 papers)Angewandte Chemie International Edition (2 papers)British Journal of Radiology (2 papers)Thyroid (2 papers)
Partner nations: France Germany United States

In The Last Decade

Jérôme Clerc

78 papers receiving 1.8k citations

Peers

Countries citing papers authored by Jérôme Clerc

Since Specialization

Citations

This map shows the geographic impact of Jérôme Clerc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Clerc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Clerc more than expected).

Fields of papers citing papers by Jérôme Clerc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Clerc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Clerc. The network helps show where Jérôme Clerc may publish in the future.

Co-authors

The 25 scholars most cited alongside Jérôme Clerc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jérôme Clerc Line = papers co-authored together Jérôme Clerc links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	¹⁸F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome Journal of Nuclear Medicine ·Anne‐Ségolène Cottereau, Christophe Nioche, Anne-Sophie Dirand, Jérôme Clerc, Franck Morschhauser, Olivier Casasnovas, Michel Meignan, Irène Buvat	2019	117
2	Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT† Annals of Oncology ·Anne‐Ségolène Cottereau, Michel Meignan, Christophe Nioche, Nicolò Capobianco, Jérôme Clerc, Loïc Chartier, Laëtitia Vercellino, Olivier Casasnovas, Catherine Thiéblemont, Irène Buvat	2020	105
3	Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma European Journal of Nuclear Medicine and Molecular Imaging ·F. Léger, M Izembart, F Dagousset, L Barritault, Georges Baillet, Alain Chevalier, Jérôme Clerc	1998	104
4	Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition Proceedings of the National Academy of Sciences ·Jérôme Clerc, M. Groll, Damir J. Illich, André S. Bachmann, Robert Huber, Barbara Schellenberg, Robert Dudler, Markus Kaiser	2009	89
5	N-Acylation during Glidobactin Biosynthesis by the Tridomain Nonribosomal Peptide Synthetase Module GlbF Chemistry & Biology ·H.J. Imker, Daniel Krahn, Jérôme Clerc, Markus Kaiser, Christopher T. Walsh	2010	78
6	Polyendocrinopathy Resulting From Pembrolizumab in a Patient With a Malignant Melanoma Journal of the Endocrine Society ·A.C. Paepegaey, C. Lheure, Carole Ratour, G. Lethielleux, Jérôme Clerc, Jérôme Bertherat, N. Kramkimel, Lionel Groussin	2017	75
7	Long-Term Radioiodine Retention and Regression of Liver Cancer after Sodium Iodide Symporter Gene Transfer in Wistar Rats Cancer Research ·J Faivre, Jérôme Clerc, René Gerolami, Julie Hervé, M. Longuet, Bingkaï Liu, Jérôme Roux, Frédéric Moal, Michel Perricaudet, Christian Bréchot	2004	60
8	Syringolin A Selectively Labels the 20 S Proteasome in Murine EL4 and Wild‐Type and Bortezomib‐Adapted Leukaemic Cell Lines ChemBioChem ·Jérôme Clerc, Bogdan I. Florea, Marianne Kraus, M. Groll, Robert Huber, André S. Bachmann, Robert Dudler, Christoph Driessen, Herman S. Overkleeft, Markus Kaiser	2009	59
9	Proteasome Activity Imaging and Profiling Characterizes Bacterial Effector Syringolin A PLANT PHYSIOLOGY ·Izabella Kołodziejek, Johana C. Misas Villamil, Farnusch Kaschani, Jérôme Clerc, Christian Gu, Daniel Krahn, Sherry Niessen, Martijn Verdoes, Lianne I. Willems, Herman S. Overkleeft, Markus Kaiser, Renier A. L. van der Hoorn	2010	56
10	Convergent Synthesis and Biological Evaluation of Syringolin A and Derivatives as Eukaryotic 20S Proteasome Inhibitors European Journal of Organic Chemistry ·Jérôme Clerc, Barbara Schellenberg, M. Groll, André S. Bachmann, Robert Huber, Robert Dudler, Markus Kaiser	2010	52
11	SIMS MICROSCOPY: METHODOLOGY, PROBLEMS AND PERSPECTIVES IN MAPPING DRUGS AND NUCLEAR MEDICINE COMPOUNDS Cell Biology International ·Jérôme Clerc, Catherine Fourré, Philippe Fragu	1997	51
12	No Major Role for the CTLA-4 Gene in the Association of Autoimmune Thyroid Disease With IDDM Diabetes ·Idriss Djilali-Saiah, Étienne Larger, Elham Harfouch-Hammoud, José Timsit, Jérôme Clerc, Éric Bertin, R Assan, Christian Boîtard, Jean‐François Bach, Sophie Caillat‐Zucman	1998	49
13	The natural product hybrid of Syringolin A and Glidobactin A synergizes proteasome inhibition potency with subsite selectivity Chemical Communications ·Jérôme Clerc, Nan Li, Daniel Krahn, M. Groll, André S. Bachmann, Bogdan I. Florea, Herman S. Overkleeft, Markus Kaiser	2010	44
14	Total Synthesis of Linoxepin through a Palladium‐Catalyzed Domino Reaction Angewandte Chemie International Edition ·Lutz F. Tietze, Svenia‐C. Duefert, Jérôme Clerc, Matthias Bischoff, Christian Maaß, Dietmar Stalke	2013	43
15	Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma Biochemical Pharmacology ·Crystal R. Archer, Dana-Lynn T. Koomoa, Erin M. Mitsunaga, Jérôme Clerc, Mariko Shimizu, Markus Kaiser, Barbara Schellenberg, Robert Dudler, André S. Bachmann	2010	39
16	Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck Surgery Annales d Endocrinologie ·Slimane Zerdoud, Anne‐Laure Giraudet, Sophie Leboulleux, Laurence Leenhardt, Stéphane Bardet, Jérôme Clerc, Marie‐Elisabeth Toubert, Abir Al Ghuzlan, Pierre‐Jean Lamy, Claire Bournaud, Isabelle Keller, F. Sébag, R. Garrel, Éric Mirallié, Lionel Groussin, Elif Hindié, David Taïeb	2017	37
17	Scintigraphic Imaging of Paediatric Thyroid Dysfunction Hormone Research in Paediatrics ·Jérôme Clerc, Hervé Monpeyssen, Alain Chevalier, F. Amegassi, Danielle Rodrigue, F.A. Leger, Bruno Richard	2008	37
18	Redifferentiating Effect of Larotrectinib in NTRK -Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer Thyroid ·Lionel Groussin, Hélène Théodon, Laura Bessiène, Leopoldine Bricaire, Fidéline Bonnet-Serrano, Béatrix Cochand‐Priollet, Karen Leroy, Simon Garinet, Éric Pasmant, Jérémie Zerbit, Romain Seban, François Goldwasser, Jérôme Clerc, Anne‐Ségolène Cottereau, Olivier Huillard	2022	35
19	Comparison Between Non-Invasive Coronary Flow Reserve and Fractional Flow Reserve to Assess the Functional Significance of Left Anterior Descending Artery Stenosis of Intermediate Severity Journal of the American Society of Echocardiography ·P. Meimoun, Smaïn Sayah, A. Luycx-Bore, J. Boulanger, F. Elmkies, Tahar Benali, H. Zemir, Luc Doutrelan, Jérôme Clerc	2011	33
20	Contribution of referent pathologists to the quality of trophoblastic diseases diagnosis Human Reproduction ·François Golfier, Jérôme Clerc, Touria Hajri, Jérôme Massardier, Lucien Frappart, Pierre Duvillard, M Rabreau, Sophie Patrier, Louise Devisme, Dominique Carles, Fanny Pelluard, B. Gasser, C. Tarranger-Charpin, Anne‐Marie Schott, D. Raudrant	2011	32

About Jérôme Clerc

Jérôme Clerc is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging, Surgery, Molecular Biology and Oncology, having authored 83 papers that have together received 1.9k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (27 papers), Thyroid Disorders and Treatments (16 papers), Cardiac Imaging and Diagnostics (8 papers), Ubiquitin and proteasome pathways (8 papers), Medical Imaging Techniques and Applications (7 papers), Head and Neck Anomalies (6 papers), Glycosylation and Glycoproteins Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (467 citations), Radiology, Nuclear Medicine and Imaging (484 citations), Pathology and Forensic Medicine (229 citations), Oncology (291 citations) and Molecular Biology (550 citations). Jérôme Clerc has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Markus Kaiser, Anne‐Ségolène Cottereau, André S. Bachmann, Olivier Casasnovas, Irène Buvat, M. Groll, Michel Meignan, Robert Dudler, Alain Chevalier and Daniel Krahn. Their work appears in journals such as Journal of Nuclear Medicine, Cancers, Angewandte Chemie International Edition, British Journal of Radiology and Thyroid.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact